Nome Químico: 1-(4-(2-Oxopiperidin-1-yl)phenyl)pyridin-2(1H)-one
Sorrisos: O=C1C=CC=CN1C2=CC=C(N3C(CCCC3)=O)C=C2
Inchi: InChI=1S/C16H15N3O4/c20-15-5-1-2-10-18(15)14-4-3-11-17(16(14)21)12-6-8-13(9-7-12)19(22)23/h3-4,6-9,11H,1-2,5,10H2
Evaluation of Crushed Tablet for Oral Administration and the Effect of Food on Apixaban Pharmacokinetics in Healthy Adults
YanSongPhD1MingChangPhD1AkiyukiSuzukiMS2Robert J.A.FrostMD, PhD3AnneKellyPhD4FrankLaCretaPhD3CharlesFrostPharmD
Clinical Therapeutics Volume 38, Issue 7, July 2016, Pages 1674-1685.e1
Development and validation of seven phenyl hydrazine chloro ester isomers (pgis) by rp-hplc-uv method in anticoagulant drug substance; apixaban
Saradhi venkata ramana v.a,b*, durga raja k.a,b, raghu babu k.a, padma m.a, jagadeesh kumar v.b, pavan kumar k. s. r.b, hemant kumar sharma
Int J Curr Pharm Res, Vol 12, Issue 2, 119-123
Stability-Indicating High-Perform ance Liquid Chrom atographie Determ ination of Apixaban in the Presence of Degradation Products
Swarup Suresh Prabhune *, Rajendra Shankar Jaguste, Prakash Laxman Kondalkar, Nitin Sharadchandra Pradhan
Sei Pharm. 2014; 82: 777-785
Analytical Quality by Design Approach for a Stability‑Indicating Method to Determine Apixaban and Its Related Impurities
Jéssica B. Ellwanger1 · Nathalie Ribeiro Wingert1 · Nadia Maria Volpato1 · Cássia Virginia Garcia1 · Elfrides E. S. Schapoval1 · Martin Steppe
Chromatographia volume 83, pages65–75(2020)